Conditions: Type 2 Diabetes
Keywords: Type II Diabetes
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 27
Healthy volunteers: no

Brief summary:
The purpose of this study is to assess the 1 month safety and tolerability after multiple oral doses of AZD1656 in patients with Type 2 Diabetes Mellitus Treated with Metformin

Detailed description:

Arms:
arm 1: Dose titration of oral suspension during 4 days to a tolerable dose given twice daily. Subjects will thereafter be treated with this dose twice daily for another 24 days arm 2: Dose titration of oral suspension during 4 days to a tolerable dose given twice daily. Subjects will thereafter be treated with this dose twice daily for another 24 days

Interventions: intervention 1: AZD1656 intervention 2: Placebo
Intervention descriptions: intervention 1: Subjects will be treated with tolerable dose twice daily for another 24 days. intervention 2: Subjects will be treated with tolerable dose twice daily for another 24 days.

Protocol document: